| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| LORAINE JA et al. | ORAL PROGESTATIONAL AGENTS. EFFECTS OF LONG-TERM ADMINISTRATION ON HORMONE EXCRETION IN NORMALLY MENSTRUATING WOMEN. | 1963 | Lancet | pmid:14052059 |
| Bell ET and Loraine JA | Urinary steroid and gonadotrophin excretion in women following long-term use of oral contraceptives. | 1967 | Lancet | pmid:4166105 |
| Watson NR et al. | Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. | 1989 | Lancet | pmid:2570971 |
| Hodgson H | Hormonal therapy for gastrointestinal angiodysplasia. | 2002 | Lancet | pmid:12020519 |
| Schleicher EM | L.E. cells after oral contraceptives. | 1968 | Lancet | pmid:4171166 |
| Kabarity A and Khodary S | Merokinetic effect of Anovlar. | 1967 | Lancet | pmid:4164318 |
| Langlands AO and Martin WM | Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer. | 1975 | Lancet | pmid:47070 |
| Mdel DG et al. | Letter: Multiple hepatic adenomas associated with an oral contraceptive. | 1975 | Lancet | pmid:48099 |
| Glassberg AB and Rosenbaum EH | Letter: Oral contraceptives and malignant hepatoma. | 1976 | Lancet | pmid:55736 |
| Bourne T et al. | Oestrogens, arterial status, and postmenopausal women. | 1990 | Lancet | pmid:1972247 |
| Corcoran R and Howard R | Low-dose progestagens and ectopic pregnancy. | 1977 | Lancet | pmid:63740 |
| Which I.U.D.? | 1977 | Lancet | pmid:68335 | |
| Stevenson JC et al. | Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. | 1990 | Lancet | pmid:1973969 |
| Stones RW | Oestrogens, arterial status, and postmenopausal women. | 1990 | Lancet | pmid:1973997 |
| CROOKE AC et al. | PREGNANCY IN WOMEN WITH SECONDARY AMENORRHOEA TREATED WITH HUMAN GONADOTROPHINS. | 1964 | Lancet | pmid:14074497 |
| Meade TW | Effects of low-oestrogen oral contraceptives. | 1978 | Lancet | pmid:75371 |
| Atkinson EA et al. | Intracranial venous thrombosis as complication of oral contraception. | 1970 | Lancet | pmid:4191549 |
| Sissons C and Hall DR | Intracranial venous thrombosis complicating oral contraception. | 1970 | Lancet | pmid:4194719 |
| Robertson-Rintoul J | Raised serum-lipids and oral contraceptives. | 1972 | Lancet | pmid:4117855 |
| Daly RJ et al. | Psychosis associated with the use of a sequential oral contraceptive. | 1967 | Lancet | pmid:4166106 |
| Tarzy BJ et al. | Rheumatic disease, abnormal serology, and oral contraceptives. | 1972 | Lancet | pmid:4115567 |
| BAINES GF | JAUNDICE IN A PATIENT TAKING NORETHISTERONE COMPOUND TABLETS. | 1965 | Lancet | pmid:14234193 |
| Ralph LJ et al. | Next steps for research on hormonal contraception and HIV. | 2013 | Lancet | pmid:23810224 |
| Howard G et al. | Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate. | 1982 | Lancet | pmid:6121092 |
| Grant EC | Avoid hormones in gastrointestinal angiodysplasia. | 2002 | Lancet | pmid:12401283 |
| Bonnar J | Letter: Progestagen-only contraception and tubal pregnancies. | 1974 | Lancet | pmid:4129743 |
| Knapp WA and Ruebner BH | Letter: Hepatomas and oral contraceptives. | 1974 | Lancet | pmid:4130279 |
| Oon CJ et al. | Hepatocellular carcinoma in a patient on oral contraception who had been exposed to hepatitis B virus. | 1979 | Lancet | pmid:89298 |
| Pike MC et al. | Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. | 1983 | Lancet | pmid:6138501 |
| Back DJ et al. | Pharmacokinetic and "potency" of contraceptive steroids. | 1984 | Lancet | pmid:6140487 |
| Horvath E et al. | Letter: Benign hepatoma in a young woman on contraceptive steroids. | 1974 | Lancet | pmid:4131203 |
| Huntington KM | Letter: Progestagen-only contraception and tubal pregnancies. | 1974 | Lancet | pmid:4131211 |
| Thom MH et al. | Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. | 1979 | Lancet | pmid:89511 |
| Serup J et al. | Natural oestrogens for oral contraception. | 1979 | Lancet | pmid:89531 |
| Manninen V and Mälkönen M | Hormones and high-density lipoproteins. | 1978 | Lancet | pmid:82719 |
| Mardell M and Zilva JF | Effect of oral contraceptives on the variations in serum-iron during the menstrual cycle. | 1967 | Lancet | pmid:4170025 |
| Burton JL et al. | Urinary coproporphyrin excretion and hepatic function in women taking oral contraceptives. | 1967 | Lancet | pmid:4170026 |
| van Cutsem E et al. | Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. | 1990 | Lancet | pmid:1970032 |
| Littlewood ER et al. | Cholangiocarcinoma and oral contraceptives. | 1980 | Lancet | pmid:6101761 |
| Ralph L et al. | Research on hormonal contraception and HIV - Authors' reply. | 2014 | Lancet | pmid:24461119 |
| SHEARMAN RP | Excretion of ovarian steroids in patients treated with an "ovulation inhibitor". | 1963 | Lancet | pmid:13977013 |
| LIND T | ORAL CONTRACEPTIVES DURING FIRST WEEKS OF PREGNANCY. | 1965 | Lancet | pmid:14247891 |
| Gray RH | Reduced risk of pelvic inflammatory disease with injectable contraceptives. | 1985 | Lancet | pmid:2859496 |
| Thornton JG et al. | Primary treatment of endometrial cancer with progestagen alone. | 1985 | Lancet | pmid:2862385 |
| Plowman PN | Treatment of menopausal symptoms in breast cancer patients. | 1988 | Lancet | pmid:2899215 |
| Briggs M and Staniford M | Oral contraceptives and blood-iron. | 1969 | Lancet | pmid:4186184 |
| di Paola G et al. | Effects of oral contraceptives. | 1967 | Lancet | pmid:4164807 |
| Urinary oestrogens in pill-users may be artefacts. | 1970 | Lancet | pmid:4195553 | |
| Jansen RP and Elliott PM | Oral contraceptives and endometrial carcinoma: Case for progesterone-receptor defect. | 1977 | Lancet | pmid:65687 |
| Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives. | 1977 | Lancet | pmid:66428 |